repurposed prexasertib (SOM Biotech)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namerepurposed prexasertib (SOM Biotech)
Drug Alias NamePrexasertib (SOM Biotech)prexasertib
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSARS-CoV-2-3C-like-proteinase inhibitors
TargetsSARS-CoV-2-3C-like-proteinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSom Biotech Sl
China Registration ClassN/A

Develop Information

Active CompaniesSom Biotech Sl
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A